SmithKline Beecham (UK and US) combines healthcare services:
This article was originally published in Clinica
SmithKline Beecham (UK/US) will combine its healthcare service businesses in a single division headed by Tadataka Yamada, chairman of the department of internal medicine at the University of Michigan medical centre. Dr Yamada will be responsible for SmithKline Beecham Clinical Laboratories; the pharmaceutical benefit management company Diversified Pharmaceutical Services; the mail order business Diversified Prescription Delivery; and the recently formed Disease Management group.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.